Literature DB >> 10438525

Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors.

D A Antonetti1, A J Barber, L A Hollinger, E B Wolpert, T W Gardner.   

Abstract

Vascular endothelial growth factor (VEGF) may have a physiologic role in regulating vessel permeability and contributes to the pathophysiology of diabetic retinopathy as well as tumor development. We set out to ascertain the mechanism by which VEGF regulates paracellular permeability in rats. Intra-ocular injection of VEGF caused a post-translational modification of occludin as determined by a gel shift from 60 to 62 kDa. This event began by 15 min post-injection and was maximal by 45 min. Alkaline phosphatase treatment revealed this modification was caused by a change in occludin phosphorylation. In addition, the quantity of extracted occludin increased 2-fold in the same time frame. The phosphorylation and increased extraction of occludin was recapitulated in retinal endothelial cells in culture after VEGF stimulation. The data presented herein are the first demonstration of a change in the phosphorylation of this transmembrane protein under conditions of increased endothelial permeability. In addition, intra-ocular injection of VEGF also caused tyrosine phosphorylation of ZO-1 as early as 15 min and increased phosphorylation 4-fold after 90 min. In conclusion, VEGF rapidly increases occludin phosphorylation as well as the tyrosine phosphorylation of ZO-1. Phosphorylation of occludin and ZO-1 likely contribute to regulated endothelial paracellular permeability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438525     DOI: 10.1074/jbc.274.33.23463

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  180 in total

Review 1.  The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment.

Authors:  G B Arden
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

Review 2.  The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group.

Authors:  T W Gardner; D A Antonetti; A J Barber; E Lieth; J A Tarbell
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

3.  Interleukin-1β-induced barrier dysfunction is signaled through PKC-θ in human brain microvascular endothelium.

Authors:  Robert R Rigor; Richard S Beard; Olesya P Litovka; Sarah Y Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-07       Impact factor: 4.249

4.  Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Lloyd Paul Aiello; Roy W Beck; Neil M Bressler; Susan B Bressler; Allison R Edwards; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Kellee M Miller; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2010-04-28       Impact factor: 12.079

Review 5.  Shear stress and the endothelial transport barrier.

Authors:  John M Tarbell
Journal:  Cardiovasc Res       Date:  2010-06-12       Impact factor: 10.787

6.  Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction.

Authors:  Paul M Titchenell; Cheng-Mao Lin; Jason M Keil; Jeffrey M Sundstrom; Charles D Smith; David A Antonetti
Journal:  Biochem J       Date:  2012-09-15       Impact factor: 3.857

7.  Zonula occludens-1 (ZO-1) redistribution is involved in the regulation of cell dissociation in pancreatic cancer cells.

Authors:  Xiaodong Tan; Hiroshi Egami; Shinji Ishikawa; Takashi Kurizaki; Masahiko Hirota; Michio Ogawa
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

8.  Loss of caveolin-1 causes blood-retinal barrier breakdown, venous enlargement, and mural cell alteration.

Authors:  Xiaowu Gu; Steven J Fliesler; You-Yang Zhao; William B Stallcup; Alex W Cohen; Michael H Elliott
Journal:  Am J Pathol       Date:  2013-12-08       Impact factor: 4.307

Review 9.  Blood-brain barrier breakdown in septic encephalopathy and brain tumours.

Authors:  D C Davies
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

10.  CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions.

Authors:  Georgette L Suidan; Jonathan W Dickerson; Yi Chen; Jeremiah R McDole; Pulak Tripathi; Istvan Pirko; Kim B Seroogy; Aaron J Johnson
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.